Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis for Vulvar Excision
NCT03578965Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2018
- Primary completion
- Nov 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of cefazolin in surgical site infection (SSI), sponsored by Washington University School of Medicine. Started Jul 2018; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03578965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03578965.